ArticlePlastic and reconstructive surgery. Global open2026
Treatment and Prevention of Traumatic Eyebrow Cicatricial Alopecia With Stem Cell Growth Serum.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Up to 16.6% of facial lacerations involve the eyebrows, and regional scarring often results in hair loss known as cicatricial alopecia (CA). Secondary CA following eyebrow lacerations is often irreversible, resulting in poor aesthetic outcomes and psychological distress. The current gold standard for treating CA is hair transplantation, but this is a painful and invasive procedure. We present 2 cases of patients who experienced eyebrow lacerations, 1 with chronic secondary CA and the other in the setting of acute facial trauma without eyebrow CA. Serial daily topical application of stem cell serum (Calecim) was commenced for both patients. Following 6 months of treatment, the patient with chronic secondary CA experienced regrowth of eyebrow hair, whereas the patient treated earlier retained their eyebrow hair and did not develop secondary CA. We propose stem cell serum as an effective, noninvasive treatment option for patients with chronic secondary CA to aid in hair regrowth. Furthermore, stem cell serum could be considered as an early treatment in acute eyebrow trauma for the prevention of CA development and hair retention.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.